Michael M. Strage serves as Executive at AngioGenex, Inc., where they oversee executive responsibilities. Since joining the company, Michael M. Strage has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jul 6, 2021 involved receiving (via award) 270,000 shares valued at $4.0B.
Michael M. Strage currently holds 6,043,014 shares of AngioGenex, Inc. (AGGX.OB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael M. Strage has been a net neutral trader of AGGX.OB stock. They have purchased $0 and sold $0 worth of shares.
Michael M. Strage's most recent insider trade was on Jul 6, 2021, when they sold 270,000 shares at $15000.00 per share.
Get notified when new Form 4 filings are submitted
| 202,011 |
| $0.14 |
| Discretionary |